163 related articles for article (PubMed ID: 3004219)
1. Ovarian carcinoma of low malignant potential: staging and treatment.
Nation JG; Krepart GV
Am J Obstet Gynecol; 1986 Feb; 154(2):290-3. PubMed ID: 3004219
[TBL] [Abstract][Full Text] [Related]
2. The role of second-look laparotomy in treatment of epithelial ovarian cancer.
McCusker MC; Hoffman JS; Curry SL; Koulos JP; Gondos B
Gynecol Oncol; 1987 Sep; 28(1):83-8. PubMed ID: 3653773
[TBL] [Abstract][Full Text] [Related]
3. Activity of chemotherapy in mucinous epithelial ovarian cancer: a retrospective study.
Pisano C; Greggi S; Tambaro R; Losito S; Iodice F; Di Maio M; Ferrari E; Falanga M; Formato R; Iaffaioli VR; Pignata S
Anticancer Res; 2005; 25(5):3501-5. PubMed ID: 16101169
[TBL] [Abstract][Full Text] [Related]
4. Platinum-based chemotherapy for advanced-stage serous ovarian carcinoma of low malignant potential.
Barakat RR; Benjamin I; Lewis JL; Saigo PE; Curtin JP; Hoskins WJ
Gynecol Oncol; 1995 Dec; 59(3):390-3. PubMed ID: 8522261
[TBL] [Abstract][Full Text] [Related]
5. Ovarian epithelial tumors of low malignant potential.
Chien RT; Rettenmaier MA; Micha JP; DiSaia PJ
Surg Gynecol Obstet; 1989 Aug; 169(2):143-6. PubMed ID: 2756462
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics and prognosis of mucinous tumors of the ovary.
Kikkawa F; Nawa A; Kajiyama H; Shibata K; Ino K; Nomura S
Gynecol Oncol; 2006 Oct; 103(1):171-5. PubMed ID: 16546243
[TBL] [Abstract][Full Text] [Related]
7. The value of CA 125 measurement before second-look laparotomy in patients with ovarian carcinoma.
Hørding U; Toftager-Larsen K; Lund B; Dreisler A; Daugaard S; Lundvall F; Knudsen JB; Bock JE
Eur J Gynaecol Oncol; 1994; 15(3):217-21. PubMed ID: 7957327
[TBL] [Abstract][Full Text] [Related]
8. For women receiving chemotherapy for clinically apparent early ovarian cancer, is there a benefit to surgical staging?
Dizon DS; Restivo A; Lomme M; Charbonneau N; Brard L; Hughes T; Weitzen S; Legare R; Granai CO; Disilvestro P
Am J Clin Oncol; 2008 Feb; 31(1):39-42. PubMed ID: 18376226
[TBL] [Abstract][Full Text] [Related]
9. Place of second-look laparotomy after 18 courses of chemotherapy in epithelial ovarian cancer.
Ngan HY; Wong LC; Ma HK
Aust N Z J Obstet Gynaecol; 1989 Feb; 29(1):52-4. PubMed ID: 2562603
[TBL] [Abstract][Full Text] [Related]
10. Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study.
Winter WE; Maxwell GL; Tian C; Sundborg MJ; Rose GS; Rose PG; Rubin SC; Muggia F; McGuire WP;
J Clin Oncol; 2008 Jan; 26(1):83-9. PubMed ID: 18025437
[TBL] [Abstract][Full Text] [Related]
11. Clinical aspects of ovarian tumors of low malignant potential.
Dgani R; Blickstein I; Shoham Z; Czernobilsky B; Ben-Hur H; Shani A; Katz Z; Borenstein R
Eur J Obstet Gynecol Reprod Biol; 1990; 35(2-3):251-8. PubMed ID: 2159428
[TBL] [Abstract][Full Text] [Related]
12. Characteristics and treatment outcomes of patients with malignant transformation arising from mature cystic teratoma of the ovary: experience at a single institution.
Oranratanaphan S; Khemapech N
Asian Pac J Cancer Prev; 2013; 14(8):4693-7. PubMed ID: 24083728
[TBL] [Abstract][Full Text] [Related]
13. Stage I ovarian carcinoma: specialty-related differences in survival and management.
Puls LE; Carrasco R; Morrow MS; Blackhurst D
South Med J; 1997 Nov; 90(11):1097-100. PubMed ID: 9386050
[TBL] [Abstract][Full Text] [Related]
14. [The value of cytoreductive second-look surgery in advanced epithelial ovarian carcinoma].
Sevelda P; Barrada M; Vavra N; Denison U; Schmidl S; Genger H; Salzer H
Wien Klin Wochenschr; 1990 Aug; 102(15):441-3. PubMed ID: 2402929
[TBL] [Abstract][Full Text] [Related]
15. Negative second-look laparotomy does not preclude recurrence in stage I ovarian carcinoma of any histological variety.
Schneider J; Centeno MM; Montoya F; Rodriguez-Escudero FJ
Eur J Gynaecol Oncol; 1993; 14(1):36-9. PubMed ID: 8472729
[TBL] [Abstract][Full Text] [Related]
16. Staging laparotomy in early epithelial ovarian carcinoma.
Helewa ME; Krepart GV; Lotocki R
Am J Obstet Gynecol; 1986 Feb; 154(2):282-6. PubMed ID: 3946515
[TBL] [Abstract][Full Text] [Related]
17. Synchronous ovarian endometrioid adenocarcinoma and endocervical mucinous adenocarcinoma.
Huang YD; Hung YC; Yeh LS; Chiang IP; Zeng GC; Chang WC
Taiwan J Obstet Gynecol; 2006 Sep; 45(3):264-7. PubMed ID: 17175478
[TBL] [Abstract][Full Text] [Related]
18. [Stage III and IV epithelial cancer of the ovary. Prognostic role of surgical tumor reduction].
Le Bouedec G; Ben Ahmed S; Plagne R; Dauplat J
Presse Med; 1990 Mar; 19(11):506-10. PubMed ID: 2138748
[TBL] [Abstract][Full Text] [Related]
19. Surgical staging in patients with ovarian tumors of low malignant potential.
Winter WE; Kucera PR; Rodgers W; McBroom JW; Olsen C; Maxwell GL
Obstet Gynecol; 2002 Oct; 100(4):671-6. PubMed ID: 12383532
[TBL] [Abstract][Full Text] [Related]
20. Role of neoadjuvant chemotherapy in the management of advanced ovarian cancer.
Zhao D; Wu LY; Wang XB; Li XG
Asian Pac J Cancer Prev; 2015; 16(6):2369-73. PubMed ID: 25824766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
